Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief Technology Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 74,348 |
Ending reported balance
After 2026-10-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 1,340 · Balance 71,975 Row 2 · 2026-10-01 · Exercise / conversion · Acquired 1,668 · Balance 73,643 Row 3 · 2026-10-01 · Exercise / conversion · Acquired 3,324 · Balance 76,967 Row 4 · 2026-10-01 · Exercise / conversion · Acquired 1,701 · Balance 78,668 Row 5 · 2026-10-01 · Tax withholding · Disposed 4,320 · Balance 74,348 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 1,340 · Balance 0 F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 1,668 · Balance 0 F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 13,296 |
Reported balance
After 2026-10-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-10-01 · Exercise / conversion · Disposed 3,324 · Balance 13,296 F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 10,202 |
Reported balance
After 2026-10-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-10-01 · Exercise / conversion · Disposed 1,701 · Balance 10,202 F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 04, 2024 Filed Nov 5, 2024 21:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 9,756 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000255 · wk-form4_1730842572.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,756 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on November 4, 2020, of which 9,756 shares were outstanding on May 3, 2023, when the Reporting Person was elected as an executive officer. These shares vest 100% on November 4, 2024. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 4,945 | $23.60 | $116,702.00 |
DisclosureSEC source: 0001576280-24-000255 · wk-form4_1730842572.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,625 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 9,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000255 · wk-form4_1730842572.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:50 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 6,569 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000234 · wk-form4_1727902210.xml · derivative · entry 5 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,338 Underlying: Common Stock · 6,569 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:50 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,339 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000234 · wk-form4_1727902210.xml · derivative · entry 4 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,714 Underlying: Common Stock · 1,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:50 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 4,009 | $22.12 | $88,679.08 |
DisclosureSEC source: 0001576280-24-000234 · wk-form4_1727902210.xml · nonDerivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,814 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:50 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 6,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000234 · wk-form4_1727902210.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:50 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000234 · wk-form4_1727902210.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2024 Filed Sep 10, 2024 20:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 2,909 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000206 · wk-form4_1726001909.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,909 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on September 11, 2020, of which 5,817 shares were outstanding on May 3, 2023, when elected as an executive officer. These shares vest 25% on September 9, 2023, and September 9, 2024. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 09, 2024 Filed Sep 10, 2024 20:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,260 | $23.77 | $29,950.20 |
DisclosureSEC source: 0001576280-24-000206 · wk-form4_1726001909.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,915 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 09, 2024 Filed Sep 10, 2024 20:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 2,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000206 · wk-form4_1726001909.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 20:45 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 316 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000198 · wk-form4_1725396313.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,263 Underlying: Common Stock · 316 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares are outstanding on May 3, 2023, when elected as an executive officer. These shares vest in equal quarterly installments on the anniversary of 9/1/2022, and fully vested on 9/1/2025. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 20:45 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 113 | $25.58 | $2,890.54 |
DisclosureSEC source: 0001576280-24-000198 · wk-form4_1725396313.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,266 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 20:45 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 316 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000198 · wk-form4_1725396313.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,339 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000164 · wk-form4_1719953576.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,053 Underlying: Common Stock · 1,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 478 | $28.26 | $13,508.28 |
DisclosureSEC source: 0001576280-24-000164 · wk-form4_1719953576.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,063 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000164 · wk-form4_1719953576.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 315 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000124 · wk-form4_1717453290.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,579 Underlying: Common Stock · 315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares are outstanding on May 3, 2023, when elected as an executive officer. These shares vest in equal quarterly installments on the anniversary of 9/1/2022, and fully vested on 9/1/2025. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 113 | $27.10 | $3,062.30 |
DisclosureSEC source: 0001576280-24-000124 · wk-form4_1717453290.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,202 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000124 · wk-form4_1717453290.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 8,705 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000113 · wk-form4_1715897521.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,116 Underlying: Common Stock · 8,705 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on August 7, 2023 and vests over a four-year period. 25% of the shares subject to such award vests on the one-year anniversary of May 15, 2023, and the remaining 75% vests annually during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 3,106 | $25.75 | $79,979.50 |
DisclosureSEC source: 0001576280-24-000113 · wk-form4_1715897521.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,000 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 8,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000113 · wk-form4_1715897521.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,340 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000078 · wk-form4_1712095434.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,392 Underlying: Common Stock · 1,340 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 527 | $20.25 | $10,671.75 |
DisclosureSEC source: 0001576280-24-000078 · wk-form4_1712095434.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,304 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000078 · wk-form4_1712095434.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,831 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 23:34 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 316 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000049 · wk-form4_1709595234.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,894 Underlying: Common Stock · 316 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares are outstanding on May 3, 2023, when elected as an executive officer. These shares vest in equal quarterly installments on the anniversary of 9/1/2022, and fully vested on 9/1/2025. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 23:34 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 130 | $18.97 | $2,466.10 |
DisclosureSEC source: 0001576280-24-000049 · wk-form4_1709595234.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,491 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 23:34 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 316 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000049 · wk-form4_1709595234.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2024 Filed Jan 17, 2024 00:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 6,626 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001576280-24-000024 · wk-form4_1705452286.xml · derivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,356 Underlying: COMMON STOCK · 6,626 shares Expires 2028-08-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018. Read SEC document |
| January 16, 2024 Filed Jan 17, 2024 00:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 6,626 | $8.80 | $58,308.80 |
DisclosureSEC source: 0001576280-24-000024 · wk-form4_1705452286.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:42 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 1,339 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000004 · wk-form4_1704328944.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,732 Underlying: COMMON STOCK · 1,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:42 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 549 | $27.05 | $14,850.45 |
DisclosureSEC source: 0001576280-24-000004 · wk-form4_1704328944.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,679 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:42 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000004 · wk-form4_1704328944.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:17 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 19,907 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000209 · wk-form4_1702678669.xml · derivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,907 Underlying: COMMON STOCK · 19,907 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:17 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 29,861 | $0.00 Strike: $28.37 | $0.00 |
DisclosureSEC source: 0001576280-23-000209 · wk-form4_1702678669.xml · derivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,861 Underlying: COMMON STOCK · 29,861 shares Expires 2033-12-13 F1 · derivative.exercise_date: This represents a stock option granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 315 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000197 · wk-form4_1701732236.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,210 Underlying: COMMON STOCK · 315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares are outstanding on May 3, 2023, when elected as an executive officer. These shares vest in equal quarterly installments on the anniversary of 9/1/2022, and fully vested on 9/1/2025. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 109 | $26.33 | $2,869.97 |
DisclosureSEC source: 0001576280-23-000197 · wk-form4_1701732236.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,889 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000197 · wk-form4_1701732236.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001576280-23-000193 · wk-form4_1700172284.xml · derivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,982 Underlying: COMMON STOCK · 4,000 shares Expires 2028-08-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 4,000 | $8.80 | $35,200.00 |
DisclosureSEC source: 0001576280-23-000193 · wk-form4_1700172284.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 5,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000165 · wk-form4_1696281377.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,071 Underlying: COMMON STOCK · 5,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 1,853 | $29.64 | $54,922.92 |
DisclosureSEC source: 0001576280-23-000165 · wk-form4_1696281377.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,683 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 5,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000165 · wk-form4_1696281377.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2023 Filed Sep 29, 2023 22:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,500 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001576280-23-000161 · wk-form4_1696026970.xml · derivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,982 Underlying: COMMON STOCK · 4,500 shares Expires 2028-08-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018. Read SEC document |
| September 28, 2023 Filed Sep 29, 2023 22:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 4,500 | $8.80 | $39,600.00 |
DisclosureSEC source: 0001576280-23-000161 · wk-form4_1696026970.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2023 Filed Sep 11, 2023 21:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 2,908 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000147 · wk-form4_1694469166.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,909 Underlying: COMMON STOCK · 2,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on September 11, 2020, of which 5,817 shares were outstanding on May 3, 2023, when elected as an executive officer. These shares vest 25% on September 9, 2023, and September 9, 2024. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 09, 2023 Filed Sep 11, 2023 21:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 1,006 | $33.72 | $33,922.32 |
DisclosureSEC source: 0001576280-23-000147 · wk-form4_1694469166.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,680 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 09, 2023 Filed Sep 11, 2023 21:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 2,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000147 · wk-form4_1694469166.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,686 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 316 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000143 · wk-form4_1693947557.xml · derivative · entry 9 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,525 Underlying: COMMON STOCK · 316 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares are outstanding on May 3, 2023, when elected as an executive officer. These shares vest in equal quarterly installments on the anniversary of 9/1/2022, and fully vested on 9/1/2025. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.